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Platelet-derived growth factor receptor alpha (PDGFRα) is a cell-surface receptor tyrosine
kinase for platelet-derived growth factors. Correct timing and level of Pdgfra expression is
crucial for embryo development, and deletion of Pdgfra caused developmental defects of
multiple endoderm and mesoderm derived structures, resulting in a complex phenotypes
including orofacial cleft, spina bifida, rib deformities, and omphalocele in mice. However, it is
not clear if deletion of Pdgfra at different embryonic stages differentially affects these
structures.
Purpose
To address the temporal requirement of Pdgfra in embryonic development.
Methods
We have deleted the Pdgfra in Pdgfra-expressing tissues at different embryonic stages in
mice, examined and quantified the developmental anomalies.
Results
Current study showed that (i) conditional deletion of Pdgfra at different embryonic days
(between E7.5 and E10.5) resulted in orofacial cleft, spina bifida, rib cage deformities, and
omphalocele, and (ii) the day of Pdgfra deletion influenced the combinations, incidence and
severities of these anomalies. Deletion of Pdgfra caused apoptosis of Pdgfra-expressing tis-
sues, and developmental defects of their derivatives.
Conclusion
Orofacial cleft, spina bifida and omphalocele are among the commonest skeletal and
abdominal wall defects of newborns, but their genetic etiologies are largely unknown. The
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remarkable resemblance of our conditional Pdgfra knockout embryos to theses human con-
genital anomalies, suggesting that dysregulated PDGFRA expression could cause these
anomalies in human. Future work should aim at defining (a) the regulatory elements for the
expression of the human PDGFRA during embryonic development, and (b) if mutations /
sequence variations of these regulatory elements cause these anomalies.
Introduction
Platelet-derived growth factor (PDGF) was identified as a serum protein that stimulated the
growth and migration of vascular smooth muscle cells, fibroblasts and glial cells [1–3]. In
human and mouse, the PDGF family is composed of four different polypeptide chains
(PDGF-A, -B, -C and -D) encoded by four different genes (PDGF-A, -B, -C and -D) [4–6].
PDGFs are secreted as homodimeric proteins (PDGF-AA, -BB, -CC and -DD) linked by two
cysteine bridges. Only PDGF-A and PDGF-B are able to form heterodimer of PDGF-AB [6].
PDGFs bind to and signal through two cell-surface receptor tyrosine kinases, PDGFRα and
PDGFRβ [7, 8]. PDGFRα has a broader specificity and bind PDGF-A, PDGF-B and PDGF-C,
whereas PDGFR-β preferably binds PDGF-B and PDGF-D. PDGF-PDGFR signaling controls
cellular proliferation, survival, migration and differentiation [9–11]. Gene knockout studies in
mice have revealed critical roles of PDGFs and PDGFRs in embryo development.
PDGFRα is a transmembrane protein with an extracellular ligand binding domain and an
intracellular tyrosine kinase domain, and functions as a typical receptor tyrosine kinase
(RTK). PDGFRα binds homodimers of PDGF-A, PDGF-B, PDGF-C and heterodimer
PDGF-AB [7, 8]. PDGFRα exists as monomeric form and PDGF binding dimerizes PDGFRαs,
and activates the receptor’s kinase activity. Tyrosine phosphorylation of the receptor itself and
other substrates triggers intracellular signaling cascades, including Ras-MAPK (mitogen acti-
vated protein kinase), phosphatidylinositol 3-kinase (PI3K) and phospholipase CU pathways,
which are essential for cellular proliferation, survival, migration and differentiation [10].
In mouse, Pdgfra was broadly expressed in primitive endoderm and mesoderm derivatives
thorough embryogenesis, in that Pdgfra mRNA was detected in the visceral endoderm at E6.5,
later after gastrulation, Pdgfra mRNA was detected in many areas of mesenchyme derivatives,
including the somites, limb bud and branchial arches [12–14]. Deletion of Pdgfra induced
embryonic lethality between E12 and E14, and caused defective development of many endo-
derm and mesoderm derived structures, resulting in cleft face, subepidermal blebbing, spina
bifida, vertebrae and rib deformities, malformation of the shoulder girdle, hemorrhaging, and
body wall musculature defect in Pdgfra null embryos [10, 11, 15]. In contrast, loss of Pdgfrb
affected the development of a more restricted set of cell types, including the vascular smooth
muscle cells such as the pericytes and the kidney mesangial cells, and that mice deficient of
Pdgfrbdisplayed severe systemic vasculature defects and died shortly after birth [16, 17].
Sequence variants in the promoter and the 3’ untranslated region of PDGFRA gene have
been identified to be associated with a number of human congenital developmental anomalies,
which includes cleft palate [18], neural tube defects (spina bifida and anencephaly) [19–23],
corneal astigmatism [24], and heart inflow tract defects [25], and some of these sequence vari-
ants affected the PDGFRA gene expression [18, 23]. Taken together with the results of Pdgfra
knockout studies, it is clear that the correct time and level of expression of Pdgfra during
embryonic development is crucial for proper development of many embryonic structures.
However, it is not clear if deletion of Pdgfra at different embryonic stages differentially affects
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the development of these structures. To address the temporal requirement of Pdgfra in embry-
onic development, we have deleted the Pdgfra in Pdgfra-expressing tissues at different embry-
onic stages using a tamoxifen inducible Cre-loxP approach in mice, examined and quantified
the developmental anomalies. Current study showed that conditional deletion of Pdgfra in
Pdgfra-expressing tissues at different embryonic days (between E7.5 and E10.5) resulted in
multiple developmental anomalies of the frontonasal region, the cranium, the vertebrae and
the rib cage, and the abdominal wall in mice. Furthermore, the day at which Pdgfra was deleted




The Pdgfrafl/fl [15] and PdgfraCre/ERT (B6N;SJL-Tg(Pdgfr-a-cre/ERT)467Dbe/J) [26] mouse
strains were purchased from The Jackson Laboratory. A cDNA encoding tamoxifen-inducible
Cre recombinase (CreERT) was inserted after the Pdgfra 5’UTR and followed by a rabbit β-glo-
bin poly A sequence in a mouse BAC clone (RP24-148N, BACPAC resource center, CHORI),
that contained the mouse Pdgfra gene with 71kb upstream of the ATG and 41kb downstream
of last coding exon. The BAC transgene was injected into pronuclei of one- or two-cell stage
embryos of B6SJL mice to generate the PdgfraCre/ERT transgenic mouse strain [26]. The
Pdgfrafl/flmice were maintained in C57BL/6JEi and the PdgfraCre/ERT mice were maintained in
C57BL/6NJ.
All mice were supplied with food and water ad libitum, and kept under pathogen-free con-
dition with a 12 h light/dark cycle. The morning the vaginal plug was observed was considered
as embryonic day 0 (E0). All experiments were carried out in accordance with protocols
approved by the Committee on the Use of Live Animals in Teaching & Research, The Univer-
sity of Hong Kong (CULATR No.: 3123–13, 3368–14; 3566–15).
Genotyping
Genomic DNA was extracted from 2 mm tail clip using PBND extraction method (http://
www.jax.org/imr/tail_nonorg.html). In brief, mouse-tail was digested with 40 mg Proteinase K
(Invitrogen™) in 200 μl PBND buffer at 55˚C for 16 hours. After heating at 96˚C for 10 minutes
to inactivate the Proteinase K, the tail digest was used as template DNA for PCR analysis. PCR
reaction was performed in PCR buffer (25 μl) containing 0.2 mM dNTP (Promega), forward
and reverse primer (0.2 μM each), template DNA (1 μl), DMSO (5%; v/v, Merck), MgCl2 (4
mM) and 0.25 μl of Ampli Taq GoldTM (Roche). Amplication was performed with forward
and reverse primers specific for the Cre, wild-type and floxed Pdgfra and Sry. PCR products
were resolved by running in a 1% (W/V) agarose gel (S1 Fig). Details of primers and sizes of
their respective PCR products were shown in S1 Table.
To distinguish PdgfraCre/ERT; Pdgfrafl/fl (CKO) and PdgfraCre/ERT; Pdgfrafl/+, we determined
the copy number of Pdgfra by copy number assay with primers (Copy Forward & Copy Reverse)
and TaqMan probe specific for the wild-type Pdgfra allele (S1 Fig). These primers and TaqMan
probe will amplify and detect the wild-type Pdgfra and the PdgfraCre/ERT allele but not the
Pdgfrafl allele. Using the mouse Tfrc (cat# 4458366) as an internal control for the copy number,
the number of copy of Pdgfra allele were determined to distinguish PdgfraCre/ERT; Pdgfrafl/fl
(CKO) (PdgfraCre/ERT; Pdgfrafl/+ embryos (PdgfraCre/ERT; Pdgfrafl/fl (CKO) has fewer copy of
Pdgfra than PdgfraCre/ERT; Pdgfrafl/+). Copy number assays were performed following Taq-
Man1 Copy Number Assay Protocol (Applied Biosystem). Briefly, the 20 μl assay mixture
contained 2×TaqMan universal PCR Master Mix (Applied Biosystems), 1 μl of each primer,
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and 40 ng DNA Template. DNA was amplified in ABI 7900HT Fast Real-Time PCR System
(Applied Biosystems). The copy number of Pdgfra was calculated using Tfrc as internal control
using SDS software version 2.0 (Applied Biosystems). All samples were run in quadruple with
negative and positive controls. The median value of the quadruple triplicate results was
recorded.
Tamoxifen induction
Tamoxifen stock (20 mg/ml of corn oil) was prepared by warming tamoxifen (Sigma) in corn
oil at 65˚C (protected from light) until completely dissolved. Tamoxifen (0.1 mg per gram of
body weight) was administered by intragastric gavage to pregnant mice.
Morphology and histology examinations
Embryos were harvested for morphology examination for anomalies. Photos were taken with
the Olympus SZX7 microscope mounted with the Olympus DP71 High Resolution Color Digi-
tal Camera.
For histology, embryos were fixed in PFA/PBS (4% (w/v) paraformaldehyde (Sigma-
Aldrich, Steinheim, Germany) in PBS (phosphate-buffered saline, pH 7.2; Sigma-Aldrich,
Steinheim, Germany)) for 18 hours at 4˚C, dehydrated in graded series of alcohol (Merck,
Darmstadt, Germany), cleared in xylene (RCI Labscan Ltd, Bangkok, Thailand) before being
embedded in paraffin (Leica Biosystems, Richmond, IL USA). Sections (8 μm in thickness)
were prepared, mounted onto TESPA-coated microscope glass, and stained with hematoxylin
and eosin following standard protocol. Photos were taken with the Olympus SZX7 microscope
mounted with the Olympus DP71 High Resolution Color Digital Camera.
Skeletal staining
Skeletons of mouse embryos were stained with alizarin red S and alcian blue following the pro-
tocol as published previously [27]. In brief, embryos were eviscerated and then fixed in 100%
ethanol (Merck, Darmstadt, Germany) for 4 days followed with acetone for 3 days. After fixa-
tion, embryos were rinsed with water, and then incubated in staining solution containing aliz-
arin red S (0.06%; w/v; Sigma-Aldrich, Steinheim, Germany), alcian blue 8GX (0.02%; w/v;
Sigma-Aldrich, Steinheim, Germany), 5% glacial acetic acid in ethanol for 10 days. After stain-
ing, the embryos were rinsed with water, then incubated in 20% glycerol (v/v; Sigma-Aldrich,
Steinheim, Germany), 1% KOH (w/v; BDH, Poole England) at 37˚C for 8 hours, and then
incubated in the same solution at room temperature until tissue was completely cleared. Then
the solution was replaced with 50% glycerol, 80% glycerol and finally 100% glycerol (USB Cor-
poration, Cleveland, OH USA). Photos were taken with the Olympus SZX7 microscope
mounted with the Olympus DP71 High Resolution Color Digital Camera.
Whole mount beta-galactosidase activity staining
Embryos were fixed in PFA/PBS for 1 hour at 4˚C. X-gal/IPTG staining was performed at
37˚C for 18 hours as describe previously [28]. Stained embryos were fixed in PFA/PBS at 4˚C
for 18 hours, dehydrated in graded series of alcohol, cleared in toluene (RCI Labscan Ltd,
Bangkok, Thailand) before being embedded in paraffin. 10-μm-thick sections were prepared
and mounted onto TESPA-coated microscope glasses. Sections were dewaxed in toluene,
hydrated in in graded series of alcohol before being completely hydrated in water, counter-
stained with Nuclear Fast Red according to manufacturer’s protocol (Vector Lab. Inc. Burling-
ham, CA), and mounted in Faramount Aqueous Mounting Medium (Dako).
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Immuno-histochemistry
Paraffin sections (8μm in thickness) were prepared and mounted onto TESPA-coated glass
slides. Sections were dewaxed in xylene, hydrated in a graded series of alcohol and finally in
distilled water. Endogenous peroxidase activity was quenched by incubation of section in
methanol containing 3% H2O2 at room temperature for 30 minutes. After washing in water,
antigen was retrieved by incubating in 10 mM sodium citrate buffer (pH 6.0) at 95˚C for 10
minutes. After blocking in PBS-T (PBS with 0.1% Triton) supplemented with 1% Bovine
Serum Albumin (USB Corporation, Cleveland, OH USA) for 1 hour at room temperature, sec-
tions were incubated with anti-PDGFRA antibody (1:200; ab21286; Abcam) in PBS-T for over-
night at 4˚C. The sections were washed in PBS-T and secondary body incubation and signal
development were performed using EnVision Detection Systems Peroxidase/DAB, Rabbit/
Mouse system according to manufacturer’s protocol (Dako). After washing in water, sections
were counterstained with Haematoxylin, washed in water, incubated in 2% (W/V) NaHCO3
for 30 seconds before being washed in water. Sections were dehydrated in a graded series of
alcohol, dewaxed in xylene and then mounted in DPX mountant (BDH). Images were taken
with Nikon Eclipse E600 microscope mounted with Nikon Digital Camera DXM1200F.
Von Kossa staining
Paraffin sections (8 μm in thickness) were prepared and mounted onto TESPA-coated glass
slides. Sections were dewaxed in xylene, hydrated in a graded series of alcohol and finally in
distilled water. Sections were incubated with 1% AgNO3 (W/V) for 45 minutes under strong
light (60 watt tungsten lamp), washed in distilled water, then incubated with 3% (W/V)
Na2S2O3 for 5 minutes before being washed in distilled water. Sections were counterstained
with Haematoxylin, washed in water, incubated in 2% (W/V) NaHCO3 for 30 seconds before
being washed in water. Sections were dehydrated in a graded series of alcohol, dewaxed in
xylene and then mounted in DPX mountant (BDH). Images were taken with Nikon Eclipse
E600 microscope mounted with Nikon Digital Camera DXM1200F.
TUNEL assay
Apoptotic cells on sections were detected using In Situ Cell Death Detection Kit following
manufacturer’s protocol (Roche Applied Science, Indianapolis, IN, USA). Sections were
mounted in VECTORSHIELD1 mounting medium with DAPI (Vector Lab. Inc., Burlingame,
CA 94010). Images were taken with Nikon Eclipse 80i microscope (Melville, NY, USA)
mounted with SPOT RT3 microscope digital camera (DIAGNOSTIC Instruments, Inc., Ster-
ling Heights, MI, USA) under fluorescence illumination for the DAPI+ve nuclei and TUNEL
+ve cells. Photos were compiled using Adobe Photoshop 7.
To quantitate the apoptosis of the CKO embryos and the control embryos, photos of the
TUNEL stained embryo sections were taken under x100 magnification, total number of cells
of the branchial arch, somite and the abdominal wall were quantitated by counting DAPI+ve
nuclei and apoptotic cells were quantitated by counting TUNEL+ve nuclei. Percentages of apo-
ptotic cells of the respective regions of CKO and control embryos were calculated by (TUNEL
+ve nuclei/DAPI+ve nuclei) x100%. Four to five embryos of each group were included for the
analysis, three sections of each embryos were examined for the quantitation of the apoptosis.
Percentages of apoptosis were shown as mean±S.D.
Statistical analysis
Student’s t Test was performed to calculate the differences between groups, and p value less
than 0.05 was regarded as statistically significant.
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Results
Tamoxifen inducible cre-mediated deletion of gene in Pdgfra-expressing
tissues in mouse
To address the temporal requirement of Pdgfra in embryonic development, we employed
PdgfraCre/ERT transgenic mouse [26] to delete the Pdgfra gene at different embryonic days by
tamoxifen inducible Cre-loxP approach in mice, examined and quantified the developmental
anomalies of the Pdgfra conditional knockout mutants. The PdgfraCre/ERT transgenic mouse
line directed tamoxifen inducible Cre recombination in Pdgfra expressing oligonucleotides
[26], but the expression of the tamoxifen inducible Cre recombinase activity in other Pdgfra
expressing tissues has not been reported. First, we crossed the PdgfraCre/ERT mice to Rosa26R
(R26R) [29] and tested if tamoxifen induced a deletion of stuffer of the R26R loci and X-gal
expression to the regions where the endogenous Pdgfra was expressed in mouse embryos.
Tamoxifen (Tm) administration at E9.5 induced a robust X-gal expression to the mesoderm of
the cephalic region, the medial nasal process, the maxillary and mandibular processes, the
developing somites of the E11.5 embryos (Fig 1). Furthermore, X-gal expression could already
be detected in PdgfraCre/ERT; R26R embryos as early as 24 hours after Tm administration at
E9.5 (Data not shown).
Conditional knockout of Pdgfra in Pdgfra-expressing tissues in early
embryonic periods resulted in embryonic lethality
We crossed the PdgfraCre/ERT; Pdgfrafl/+ mice with Pdgfrafl/flmice and gave single dose of Tm to
the pregnant mice at E7.5, no CKO embryos could be collected at E18.5, which indicated that
knockout of Pdgfra at early embryonic day E7.5 was embryonic lethal, which was in line with
embryonic lethality of Pdgfra-/- mutant mice [11, 15]. Male and female E14.5 CKO embryos of
the E7.5 Tm treatment groups could be recovered in compliance with the expected Mendelian
inheritance, and all the E14.5 CKO embryos of the E7.5 Tm groups displayed various degree of
facial cleft, which could be attributable to the variation of cre-mediated knockout efficiency of
Pdgfra in embryos. In addition, growth retardation, subepidermal blebs (arrowhead) and
extensive hemorrphaging were also observed in mutant embryos (S2 Fig). Similar develop-
mental defects and embryonic lethality were also observed in CKO embryos when Tm was
given at E8.5 (Data not shown). The phenotypes of CKO embryos were identical to those of
Pdgfra-/- mutant mice [11, 15], which indicated that the PdgfraCre/ERT transgenic mouse [26]
directed robust and specific expression of Cre to most of the tissues that express the endoge-
nous Pdgfra gene.
Conditional knockout of Pdgfra in Pdgfra-expressing tissues in embryos
resulted in axial skeletal and body wall developmental anomalies
The early embryonic lethality of CKOs of E7.5 and E8.5 Tm groups precluded the study of the
impact of the conditional knockout of Pdgfra in the axial skeleton and body wall development
beyond E14.5. To circumvent the problem of embryonic lethality and to investigate the impact
of the conditional knockout of Pdgfra in Pdgfra-expressing tissues on the axial skeletal and
body wall development, we gave Tm to pregnant females for two consecutive days starting at a
slightly later embryonic days of E9.5, E10.5, E11.5 and E13.5, harvested embryos at E18.5 for
examination (Fig 2). Male and female E18.5 CKO embryos of all these Tm treatment groups
were recovered in compliance with the expected Mendelian inheritance (Table 1). Immuno-
histochemistry for PDGFRA on sections showed that Tm administration at E9.5 markedly
reduced the expression level of PDGFRα in E12.5 CKO embryos (S3 Fig).
Platelet-derived growth factor receptor-α in embryonic development
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From the E9.5 Tm group, 23% of CKO embryos (11 out of 48 CKO embryos) displayed a
severe midline frontal nasal clefting spanning the anterior forebrain to the frontal nasal process
(Fig 3A). Although facial cleft was not observed in all the CKO embryos, over half of the other
CKO embryos (26 out of 48 CKO embryos, 54%) showed markedly shorter snout with tongue
protrusion (Fig 3B). Histological examination revealed a lack of or retardation of skeletal
development of the frontal nasal regions in these CKO embryos (Fig 3D and 3E). In the CKO
embryos with cleft face, the nasal capsule with the frontal and nasal bones were lacking or
failed to fuse (Fig 3D). In those CKO embryos with short snout, the nasal capsule was severely
developmentally retarded and the nasal septum was lacking (Fig 3E). The palatal shelves failed
to form resulting in cleft palate in all the CKO embryos with cleft face, in that the brain com-
municated directly with the nasal and the oral cavities (Fig 4; Table 1).
All the CKO embryos of E9.5 Tm group with either cleft face or short snout (37 out of 48
CKO embryos, 77%) displayed cranial skeletal defect with the entire skull bone missing, and
the brain was covered only with the skin (Fig 3A and 3B). Exencephaly, a type of cephalic dis-
order wherein the brain was located outside of the skull, was observed in 75% of the CKO
Fig 1. PdgfraCre/ERT induced robust Cre-mediated recombination in Pdgfra-expressing tissues in
mouse embryos. We crossed the PdgfraCre/ERT mice to Rosa26R (R26R) and tamoxifen (Tm) was
administered at E9.5 by intragastic gavage. Embryos were collected at E11.5 and processed for whole mount
X-gal staining. Sagittal sectioning of the X-gal stained double transgenic (A-C) and control (D) (PdgfraCre/ERT
or R26R) littermates were shown for comparison. Highlighted regions were magnified and shown as insets.
Abbreviations: fv, forth ventricle; cm, cephalic mesenchyme; mnp, medial nasal process; max, maxillary
process; man, mandibular process; h, heart; nt, neural tube.
https://doi.org/10.1371/journal.pone.0184473.g001
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embryos with cleft face and in 50% of the CKO embryos with short snout (arrowheads; Fig 3A
and 3B). The absence of skull bone in these CKO embryos was further confirmed by Von
Kossa staining of the cranial regions (Fig 3D–3F). The neural crest derived basisphenoid bone,
the cephalic mesoderm derived bones including the supraoccipital and basioccipital bones
were either missing or retarded in the CKO embryos with cleft face or short snout (Fig 3). The
eyes were covered with eyelids in control littermates but they were not covered in CKO
embryos (Fig 3). The upper and lower eyelids of the left and right eyes of control (arrows) have
completely grown covering the cornea in controls. In contrast, the upper and lower eyelids
(arrows) were not developed in CKO embryos (Fig 4).
Skeletal abnormalities were also detected in the vertebral column and the rib cavity of the
CKO embryos of the E9.5 Tm group. All the CKO embryos displayed rib cage abnormalities of
various severities. In generally, the sternum was shorter and the rib cage was smaller in the
CKO embryos. The sternal bands failed to fuse completely resulting in a total sternal fissure in
Fig 2. Conditional deletion of Pdgfra in Pdgfra-expressing tissues in mouse embryos. (A) Crossing
scheme of PdgfraCre/ERT mice with Pdgfrafl/fl to generate conditional knockout (CKO, PdgfraCre/ERT;Pdgfrafl/fl)
and control (Ctrl, Pdgfrafl/fl) embryos. (B) Tamoxifen (Tm) was given to pregnant females at various embryo
days by intragastic gavage, and embryos were collected for the analysis.
https://doi.org/10.1371/journal.pone.0184473.g002
Table 1. Phenotypes of Pdgfra CKO embryos of different Tm groups.
Tm No. of embryo (n) Mutant (n) Cleft face Short snout Cranium defect Cleft palate Omphalocele Spina bifida
E9.5 180 48 11 (23%) 26 (54%) 37 (77%) 11 (23%) 48 (100%) 31 (65%)
E10.5 45 12 0 (0%) 1 (8%) 1 (8%) 0 (0%) 12 (100%) 2 (17%)
E11.5 23 5 0 (0%) 0 (0%) 0 (0%) 0 (0%) 5 (100%) 0 (0%)
E13.5 10 3 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
% of the CKO embryos showing the respective anomaly was shown in parenthesis
https://doi.org/10.1371/journal.pone.0184473.t001
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12% (Fig 5A), or failed to fuse at the anterior portion of the sternum resulting in a partial ster-
nal fissure in 24% of the CKO embryos (Fig 5B; Table 2). In addition, fewer ribs were detected
in these CKO embryos, and some of the ribs did not attach to the vertebrae (Fig 6 and data not
shown). The other 40% of the CKO embryos displayed a non-fusion at the caudal portion of
the sternum leaving a perforation of the sternal body, and a lack of the manubrium (Fig 5C).
In the rest of the CKO embryos, the sternum appeared relatively normal except it was shorter
and the manubrium was hypoplastic (Fig 5D).
Around 65% (31 out of 48 CKO embryos) of the CKO embryos developed spina bifida, a
birth defect where there was incomplete closure of the vertebrae and membranes around the
spinal cord (Fig 5F) (Table 1). Skeletal staining revealed that the vertebral arches of the CKO
vertebrae failed to form the convex structure as observed in the control littermate. Transverse
section of CKO embryos indicated that the vertebral arches failed to grow to cover the dorsal
side of the spinal cord, and the spinal cord was covered by a thin membrane only (arrowhead;
Fig 6a). In control littermates, neural arches grew and connected with cartilage at the dorsal
side covering the spinal cord.
Fig 3. Conditional knockout of Pdgfra in Pdgfra-expressing tissues in embryos at E9.5 resulted in multiple developmental
anomalies. PdgfraCre/ERT;Pdgfrafl/+ mice were crossed with Pdgfrafl/fl, tamoxifen was given to pregnant females at E9.5 for two consecutive
days. Conditional knockout (CKO, PdgfraCre/ERT;Pdgfrafl/fl) and control (Ctrl, Pdgfrafl/fl) embryos were collected at E18.5 for analysis.
Morphological examinations of CKO embryos (A, B) and control littermates (C). Haematoxylin and eosin staining of sagittal sections of the
head of CKO embryos (D, E) and control littermates (F). Von Kossa staining (black) of the sagittal sections of the head of CKO embryos (H, I)
and control littermate (J). Highlighted regions were magnified and shown on the right, and arrowheads indicated the positive staining of bone.
Arrowheads indicated severe midline frontonasal clefting with exencephaly, and arrows indicated omphalocele. Abbreviations: tg, tongue;
md, mandible; mx, maxilla; pa, palatal shelf; bp, basisphenoid bone; bo, basioccipital bone; nb, nasal bone; ns, nasal septum; hy, hyoid bone;
so, supraoccipital bone; ep, epidermis; de, dermis; br, brain; bo, bone.
https://doi.org/10.1371/journal.pone.0184473.g003
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All the E18.5 CKO embryos of the E9.5 Tm group showed the phenotype of omphalocele,
in which the intestines and liver remained outside of the abdomen in a sac (arrows; Fig 3;
Table 1). Transverse section of E18.5 CKO embryos revealed that the body wall musculature
was not developed properly, in that muscle could only be localized from the dorsal to the ven-
tral lateral body wall of the trunk (Fig 6b and 6c). No muscle could be detected at the ventral
body wall of the CKO embryos, and the ventral body wall was much thinner as compared to
that of the control littermates.
Conditional knockout of Pdgfra in Pdgfra-expressing tissues at later
embryonic day resulted in milder developmental anomalies
Similar skeletal abnormalities could also be detected in the CKO embryos of the E10.5 Tm
group, but in general, with lower incidence and milder severity of the abnormalities. No cleft
face and cleft palate was detected in these CKO embryos, and only 8% of the CKO embryos
showed shorter snout and a partial lack of the skull bone (Fig 7; Table 1). In addition, these
CKO embryos also exhibited defective eyelids development like the CKO embryos of E9.5 Tm
group. The rest of the CKO embryos (92%) showed normal snout length, and normal nasal
cavity with the nasal bone and the nasal septum normally developed comparable to that of the
normal control littermates. The skull bone was formed in these CKO embryos as revealed by
Von Kossa staining of the cranial region (Fig 7D–7F). The neural crest cell-derived and
cephalic mesoderm derived bones were also developed in the majority of the CKO embryos of
the E10.5 Tm group. Milder skeletal abnormalities of the rib cage and the vertebral column
were detected in the CKO embryos of the E10.5 Tm group (S4 Fig). Shorter sternum was
detected in the CKO embryos, with the missing of the manubrium or manubrium hypoplasia
in 8% and 92% of these embryos, respectively (Table 2). Spina bifida was only detected in 2
(17%) CKO embryos (Table 1). However, omphalocele was detected in all the CKO embryos
(arrows, Fig 7; Table 1). The CKO embryo of the E11.5 Tm group only showed the phenotype
of omphalocele, and the CKO embryo of the E13.5 Tm group did not develop any of the above
mentioned anomalies (Table 1).
Fig 4. Craniofacial anomalies of conditional Pdgfra knockout embryos. Coronal sections of the head of
conditional knockout (CKO, PdgfraCre/ERT;Pdgfrafl/fl) and control (Ctrl, Pdgfrafl/fl) E18.5 embryos were
processed for haematoxylin and eosin staining. In CKO embryos with cleft face, the nasal capsule failed to
fuse, and the palatal shelf (asterisk) failed to form. The cranium failed to develop, the brain was covered with a
thin skin and edema (arrowhead) was formed. Arrows indicated the eyelids.
https://doi.org/10.1371/journal.pone.0184473.g004
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Fig 5. Axial skeletal anomalies of conditional Pdgfra knockout embryos. Skeletal staining of the rib
cages of conditional Pdgfra knockout (CKO, PdgfraCre/ERT;Pdgfrafl/fl) (A-D) and control (Ctrl, Pdgfrafl/fl) (E)
embryos were shown for comparison. The ribs were numbered and arrows indicated the respective location of
the manubrium. CKO embryos developed spina bifida (arrowhead), and the vertebral arches of the CKO
vertebrae failed to form the convex structure as observed in the control littermate (F). Abbreviations: m,
manubrium; st, sternum; xp, xiphoid process; vb, vertebral body; ar, vertebral arch.
https://doi.org/10.1371/journal.pone.0184473.g005
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Taken all the above indicated that conditional knockout of Pdgfra in Pdgfra-expressing tis-
sues in mouse embryos at different embryonic days (E9.5 and E10.5) resulted in multiple
developmental anomalies of the frontonasal region, the cranium and the abdominal wall mus-
culature (Table 1). Furthermore, the day at which tamoxifen was given had a major impact on
the repertoire of the anomalies of the CKO embryos, and tamoxifen treatment at E9.5 resulted
in the development of all the anomalies.
Deletion of Pdgfra induced apoptosis
To test if deletion of Pdgfra induced apoptosis of the Pdgfra-expressing tissues in embryos,
CKO and control E12.5 embryos of E9.5 and E10.5 Tm groups were examined by TUNEL
assay. Apoptotic signals were localized at the frontonasal region (arrow), the mandibular
(arrowhead) processes, the somites, and at the developing dorsal body wall (Fig 8A–8D). Ele-
vated cell death could also be localized at the region of the cephalic mesenchyme. However,
the amount of apoptotic cells at these regions was markedly lower in the CKO embryos of
E10.5 Tm group than that of E9.5 Tm group. TUNEL staining of the transverse section of the
lumbar regions of the CKO E12.5 embryos localized abundant apoptotic cells at the somites
(marked with dotted line), the mesoderm surrounding the somites as well as at the developing
body wall. To quantitate the apoptosis of the CKO embryos and the control embryos, we deter-
mined the percentages of apoptotic cells (% apoptosis) of the frontonasal region, somite and
abdominal wall of CKO and control embryos. Percentages of apoptosis were significantly
higher in CKO embryos than their control littermates within the same Tm group (Table 3).
However, % apoptosis of the frontonasal region, and the somite of the E12.5 CKO embryos of
E10.5 Tm group were significantly lower than their respective regions of E9.5 Tm group. Inter-
estingly, % apoptosis of the abdominal wall were similarly in CKO embryos of E9.5 and E10.5
Tm groups.
To further investigate apoptosis of the somite and the abdominal wall in CKO embryos of
Tm administration at later time point, we collected and examined apoptosis of the somite and
body wall of the lumbar regions of the E13.5 control and CKO embryos of E11.5 Tm group by
TUNEL staining on sections. Apoptotic cells in the somite of the CKO embryos were as few as
that of the control embryos (S5 Fig; Table 3). In contrast, apoptotic cells were abundantly
found in the body wall of the CKO embryos (S5 Fig), and % apoptosis in the body wall of CKO
embryos was significantly higher than that of control embryos (Table 3).
Discussion
The correct time and level of expressions of Pdgfra during embryonic development is crucial
for proper development of endoderm, mesoderm derivatives. Current study showed that (i)
conditional deletion of Pdgfra in Pdgfra-expressing tissues at different embryonic days resulted
in developmental anomalies of the neural crest (NC) and somite derived structures, and (ii)
Table 2. Rib cage anomalies of Pdgfra CKO embryos of different Tm groups.
Rib cage defects E9.5 E10.5
Total sternal fissure; missing ribs; some ribs were not attached to the vertebrae 12% 0%
Partial sternal fissure; missing ribs; some ribs were not attached to the vertebrae 24% 0%
Non-fusion of the caudal portion of the sternum; perforations of the sternal body; absence of
manubrium
40% 8.3%
Hypoplasia of manubrium 24% 83%
% of the CKO embryos showing different rib cage anomalies was shown
https://doi.org/10.1371/journal.pone.0184473.t002
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Fig 6. Ventral body wall muscle defects of conditional Pdgfra knockout embryos. Haematoxylin and
eosin staining of transverse sections of the trunk region of CKO (PdgfraCre/ERT;Pdgfrafl/fl) embryos and control
(Pdgfrafl/fl) littermate (Ctrl) were shown for comparison. Highlighted regions were magnified and shown.
Abbreviations: st, stomach; li, liver; si, small intestine; sp, spinal cord; vb, vertebral body; ar, vertebral arch;
mu, muscle.
https://doi.org/10.1371/journal.pone.0184473.g006
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the day at which Pdgfra was deleted had a major impact on the combination of the anomalies
of the conditional Pdgfra knockout embryos.
The axial skeleton consists of the craniofacial skeleton, the rib cage, the sternum and the
vertebral column, and is mainly derived from cranial NC and paraxial mesoderm (somites)
[30–32]. Craniofacial skeleton is derived from two main sources of cells: the cranial NC and
the cranial mesoderm (CM) [33–38]. The cranial NC contribute to the lower and the upper
jaws, the snout, the frontal bones of the skull and the anterior skull base. The CM contributes
to the bones of the neurocranium and the posterior skull base [37, 39–41]. The rib cage and
the vertebrae are derived from somites.
Using the PdgfraCre/ERT; Pdgfrafl/+ mice and Rosa26R (R26R) [29], we showed that tamoxifen
administration at E9.5 induced a robust X-gal expression to the regions whereas the endoge-
nous Pdgfra was expressed, including the mesoderm of the cephalic region, the nasal process,
the maxillary and the mandibular processes, and the developing somites. Crossing the
PdgfraCre/ERT [26] mice with Pdgfrafl/fl [15], and giving tamoxifen at E9.5 resulted in defective
development of cranial NC derived and CM derived cartilages and bones of the frontonasal
Fig 7. Conditional knockout of Pdgfra in Pdgfra-expressing tissues at E10.5 resulted in milder developmental anomalies. PdgfraCre/ERT;
Pdgfrafl/+ mice were crossed with Pdgfrafl/fl, tamoxifen was given to pregnant females at E10.5 for two consecutive days. Conditional knockout (CKO,
PdgfraCre/ERT;Pdgfrafl/fl) and control (Ctrl, Pdgfrafl/fl) embryos were collected at E18.5 for analysis. Morphological examinations of CKO embryos (A, B)
and control littermate (C). Haematoxylin and eosin staining of sagittal sections of the head of CKO embryos (D, E) and control littermate (F). Von Kossa
staining (black) of the sagittal sections of the head of CKO embryos (H, I) and control littermate (J). Highlighted regions were magnified and shown on
the right, and arrowheads indicated the positive staining of bone. Arrows indicated omphalocele. Abbreviations: tg, tongue; md, mandible; mx, maxilla;
pa, palatal shelf; bp, basisphenoid bone; bo, basioccipital bone; nb, nasal bone; ns, nasal septum; hy, hyoid bone; so, supraoccipital bone; ep,
epidermis; de, dermis; br, brain; bo, bone.
https://doi.org/10.1371/journal.pone.0184473.g007
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Fig 8. Deletion of Pdgfra induced apoptosis. Sagittal sections of CKO (PdgfraCre/ERT;Pdgfrafl/fl) and control (Ctrl, Pdgfrafl/fl)
E12.5 embryos of E9.5 Tm group were examined by TUNEL assay (Red). Highlighted regions were magnified and shown on
the right. Number of embryos analyzed for each group was indicated as “n”, and representative photo of each group was
shown. Abbreviations: nt, neural tube; li, liver; i, intestine; drg, dorsal root ganglion.
https://doi.org/10.1371/journal.pone.0184473.g008
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region and the skull; abnormal development of the vertebrae, the rib cage, and the abdominal
wall musculature. These affected structures of the Pdgfra CKO embryos are derivative of the
cephalic mesoderm and cranial NC, mesoderm of the cephalic region, the medial and lateral
nasal processes, the 1st and the 2nd brachial arches, and the developing somites in mice. The
eyelids develop from both secondary mesenchyme and surface ectoderm, and cranial NC is
the primary source of the mesenchymal component of the eyelids. Therefore, failure of eyelid
development in the Pdgfra CKO embryos is likely due to the defective development of the mes-
enchymal derivatives of the cranial NC.
In E12.5 CKO embryos, apoptotic cells were abundantly localized at the frontonasal region,
the mandibular process, the region of the cephalic mesenchyme, the developing somites, the
mesoderm surrounding the somites as well as of the developing body wall. These data indicate
that Pdgfra is important for the survival of mesoderm and its derivatives, NC, somite and its
derivatives. Elevated apoptosis of these structures could lead to skeletal development defects in
Pdgfra CKO embryos.
The body wall development is divided into the primary and the secondary body wall forma-
tion. The ectoderm and the lateral plate mesoderm elongate laterally and coalesces at the ven-
tral midline around the umbilicus to form the primary abdominal wall enclosing the
abdominal cavity. The myoblasts migrate out of the myotome into the primary body wall and
differentiate to form the secondary body wall formation. The apoptosis of the developing body
wall of the CKO embryos could lead to the defective secondary body wall development, and
omphalocele.
NC-specific deletion of Pdgfra resulted in defects of craniofacial and aortic arch detects
[15]. Defective development of lung alveolar mesenchyme, intestinal mesenchyme, oligoden-
drocytes, Leydig cells, and the diaphragm have also been described in the population of surviv-
ing Pdgfra null mutants [42–46]. We have not detected any defect of the aortic arch, the lung
alveolar mesenchyme and the diaphragm in all the Pdgfra CKO embryos of the E9.5 Tm group
(data not shown). Lack of lung developmental defect in the Pdgfra CKO embryos could be due
to the ineffective deletion and of Pdgfra expression in the developing lung of CKO embryos of
the E9.5 Tm group (S3 Fig).
Table 3. Apoptosis of the frontonasal region, somite and abdominal wall in Pdgfra CKO embryos of different Tm groups.
Tm E9.5 E10.5 E11.5*
Control (n = 4) CKO (n = 4) Control (n = 4) CKO (n = 4) Control (n = 6) CKO (n = 5)
Region
% apoptosis % apoptosis % apoptosis
Frontonasal 2±0.3% 33.8±4.2% 1.1±0.1% 10±0.4% N.D. N.D.
p = 0.009§ p = 0.001§
p = 0.02#
Somite 2.2±1.2% 31.1±1.1% 0.9±0.1% 9.4±1.1% 1.8±0.1% 2±0.2%
p = 9.8E-05§ p = 0.007§ p = 0.1§
p = 0.002#
Abdominal wall 3.7±0.1% 16.1±2.1% 6±1.1% 17.2±0.2% 17.2±3.4% 39.2±0.8%
p = 0.02§ p = 0.006§ p = 0.01§
p = 0.58#
§: p value of comparison between control (Pdgfrafl/fl) and CKO (PdgfraCre/ERT;Pdgfrafl/fl) embryos of the same Tm group;
#: p value of comparison between CKO (PdgfraCre/ERT;Pdgfrafl/fl) embryos of the Tm E9.5 and Tm E10.5 group.
*: control (Pdgfrafl/fl) and CKO (PdgfraCre/ERT;Pdgfrafl/fl) embryos were collected at E14.5. N.D., not determined.
https://doi.org/10.1371/journal.pone.0184473.t003
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In mouse, the cardiac NC emigrates from the NT at around E8, and colonizes the outflow
tract at around E10.25 [47]. In general, Tm administration by gastric gavage of pregnant mice
in mouse induced cre-mediated deletion of floxed allele at 18 to 24 hours post administration.
Therefore, the Pdgfra gene was deleted in Pdgfra expressing tissues by E10 to E10.5 in CKO
embryos, which has already passed the critical time point of NT emigration and outflow tract
colonization of the cardiac NC. This could explain the lack of aortic arch defect in our CKO
embryos.
Present study showed that apoptosis of the frontonasal region, mandibular process, somite
and abdominal body wall of CKO embryos was greatly affected by the day at which the Pdgfra
was deleted. Pdgfra deletion at earlier embryonic stages caused excessive apoptosis of these
regions, while Pdgfra deletion at later stage resulted in much reduced apoptosis and only in a
subset of these regions. The repertoire of the anomalies of the CKO embryos correlated with
the degrees of apoptosis of these different regions.
In conclusion, conditional knockout of Pdgfra in Pdgfra-expressing tissues in mouse
embryos at different embryonic days (E9.5 and E10.5) resulted in multiple developmental
anomalies of the frontonasal region, the cranium and the abdominal wall musculature. Fur-
thermore, the day at which the Pdgfra is deleted influences the repertoire of the anomalies of
the CKO embryos.
Orofacial cleft (includes cleft lip, cleft palate, and both together), spina bifida (includes
spina bifida occulta, meningocele, and myelomeningocele) and omphalocele are among the
commonest skeletal and abdominal wall defects of newborns. The remarkable resemblance of
our conditional Pdgfra CKO embryos to theses human congenital anomalies, suggesting that
dysregulation of the time and level of the expression of PDGFRA could cause these anomalies
in human. Future work should aim at defining (a) the regulatory elements for the transcrip-
tional regulation of the human PDGFRA during embryonic development, and (b) if mutations
/ sequence variations of these regulatory elements cause these anomalies.
Supporting information
S1 Fig. PCR genotyping of mice for Cre, wild-type and floxed Pdgfra and Sry. (A) The wild-
type Pdgfra, the floxed Pdgfra locus and the PdgfraCre/ERT locus were shown. Black boxes repre-
sent exons; ATG indicates the start of translation. The floxed allele contains the Neo cassette
(gray box) and the two loxP sites (black arrowheads). Primers for PCR amplification are showed
as arrows. (B) Agarose gel electrophoresis of PCR products of genomic DNAs. PCR product
respective of PdgfraCre/ERT, wild-type Pdgfra, and the floxed Pdgfra allele were indicated with
arrows. (C) The wild-type Pdgfra locus was shown, and the locations of the forward and reverse
primers (arrows) and the TaqMan probe (black bar) for the determination of the copy number
of Pdgfra allele were shown. Locations of the restriction endonucleases were indicated.
(TIF)
S2 Fig. Conditional deletion of Pdgfra at E7.5 resulted in phenotypic abnormalities
and embryonic lethality in mutant embryos. E14.5 mutant embryos (CKO, PdgfraCre/ERT;
Pdgfrafl/fl) were generally smaller, and displayed cleft face, bleeding, subepidermal bleb (arrow-
head). Control littermate (Ctrl, Pdgfrafl/fl) was shown for comparison.
(TIF)
S3 Fig. Immuno-histochemistry for PDGFRA in CKO mutants. Conditional knockout
(CKO, PdgfraCre/ERT;Pdgfrafl/fl) and control (Ctrl, Pdgfrafl/fl) embryos were collected at E12.5 of
E9.5 Tm group for immunostaining for PDGFRA. Upper panel, immuno-reactivity for
PDGFRA (brown) were localized in the mesenchyme tissues at the fourth ventricle (A), the
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developing eye (B), and the nasal region (C, D) of the control embryos. Immuno-reactivity for
PDGFRA was absent in the mesenchyme tissues of these regions (E, F, G) of the CKO
embryos. Lower panel, immuno-reactivity for PDGFRA (brown) were localized in the somite
(A) and the developing body wall (B), but not in the CKO embryos (C, D). However, PDGFRA
protein was localized at the developing lung (arrowhead) in both CKO and control embryos.
(TIF)
S4 Fig. Rib cage anomalies of conditional Pdgfra knockout embryos. Skeletal staining of the
rib cages of conditional Pdgfra knockout (CKO, PdgfraCre/ERT;Pdgfrafl/fl) (A-B) and control
(Ctrl, Pdgfrafl/fl) (C) embryos of E10.5 Tm group were shown for comparison. The ribs were
numbered and arrows indicated the respective location of the manubrium. Abbreviations: m,
manubrium; st, sternum; xp, xiphoid process.
(TIF)
S5 Fig. Deletion of Pdgfra induced apoptosis. Sagittal sections of CKO (A, PdgfraCre/ERT;
Pdgfrafl/fl) and control (B, Ctrl, Pdgfrafl/fl) E14.5 embryos of E11.5 Tm group were examined by
TUNEL assay (Red). Highlighted regions were magnified and shown on the right. Number of
embryos analyzed for each group was indicated as “n”, and representative photo of each group
was shown. Abbreviations: nt, neural tube; li, liver; i, intestine.
(TIF)
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